Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bingjie Fan
Institutions:
Beijing University of Chinese Medicine,
Shandong Tumor Hospital,
China Academy of Chinese Medical Sciences,
Guang’anmen Hospital,
Shandong First Medical University
Observed institutions:
Beijing University of Chinese Medicine,
Shandong Tumor Hospital,
China Academy of Chinese Medical Sciences,
Guang’anmen Hospital,
Shandong First Medical University
ORCID:
0000-0002-6917-731X
Observed ORCID:
0000-0002-6917-731X
OpenAlex ID:
A5087612064
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer
2024
·
Butuo Li
, Wenru Qin
, et al.
·
Journal of Translational Medicine
·
30
PDF
Outcome-Supervised Deep Learning on Pathologic Whole Slide Images for Survival Prediction of Immunotherapy in Patients with Non–Small Cell Lung Cancer
2023
·
Butuo Li
, Linlin Yang
, et al.
·
Modern Pathology
·
26
PDF
Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer
2022
·
Wenru Qin
, Linlin Yang
, et al.
·
Frontiers in Immunology
·
19
PDF
A novel deep learning prognostic system improves survival predictions for stage III non‐small cell lung cancer
2022
·
Linlin Yang
, Xinyu Fan
, et al.
·
Cancer Medicine
·
19
PDF
Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer
2022
·
Butuo Li
, Chao Jiang
, et al.
·
BMC Cancer
·
13
PDF
Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab
2023
·
Butuo Li
, Linlin Yang
, et al.
·
Frontiers in Oncology
·
12
PDF
Deep learning for survival prediction in triple-negative breast cancer: development and validation in real-world cohorts
2025
·
Yiyue Xu
, Butuo Li
, et al.
·
Scientific Reports
·
8
PDF
NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma
2022
·
Yiyue Xu
, Bing Zou
, et al.
·
Aging
·
8
PDF
Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial
2024
·
Xiaochu Man
, Jie Huang
, et al.
·
Clinical and Translational Medicine
·
7
CT-based radiomics in predicting the efficacy of preoperative neoadjuvant chemoimmunotherapy for non-small cell lung cancer: a systematic review and meta-analysis
2026
·
Hongyang Chen
, Bingjie Fan
, et al.
·
Frontiers in Immunology
·
5
PDF
Impact of Nab-Paclitaxel Plus PD-1/PD-L1 Inhibitor on Chemorefractory Relapsed Small-Cell Lung Cancer
2023
·
Fengchun Mu
, Bingjie Fan
, et al.
·
Future Oncology
·
3
Induction Serplulimab and Chemotherapy Followed by Chemoradiotherapy for Bulky Unresectable Stage III NSCLC: A Phase II Study (SUCCEED-01)
2026
·
Chengxin Liu
, Yang Du
, et al.
·
Cancer Immunology Research
·
1
945 Serplulimab-Based Induction and Sequential Chemoradiotherapy for Bulky Unresectable Stage III NSCLC: Study Design and Preliminary Results
2025
·
Chengxin Liu
, Dan Han
, et al.
·
Radiotherapy and Oncology
·
1
Abstract OT1-05-02: Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
2023
·
Huihui Li
, Qiaorui Tan
, et al.
·
Cancer Research
·
1
Impact of Nab-Paclitaxel Plus PD-1/PD-L1 Inhibitor on Chemorefractory Relapsed Small-Cell Lung Cancer
2026
·
Fengchun Mu
, Bingjie Fan
, et al.
·
Figshare
Predicting T790M mutation status in non-small cell lung cancer based on radiomics: A systematic review and meta-analysis
2026
·
Hongyang Chen
, Bingjie Fan
, et al.
·
PLoS ONE
Abstract 6487: Exploratory study of camrelizumab combined with chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma
2026
·
Linlin Wang
, Bingjie Fan
, et al.
·
Cancer Research
Traditional Chinese Medicine in Febrile Neutropenia Treatment: Advances and Prospects
2025
·
Kangdi Cao
, Jinkun Wang
, et al.
·
Future Integrative Medicine
PDF
Abstract PO3-06-07: Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
2024
·
huihui Li
, Dongdong Zhou
, et al.
·
Cancer Research
Abstract PO4-04-07: Efficacy, safety and translational study of pyrotinib combined with albumin-bound paclitaxel as firstline treatment of HER-2 positive metastatic breast cancer
2024
·
Huihui Li
, Xiaochu Man
, et al.
·
Cancer Research
Impact of Nab-Paclitaxel Plus PD-1/PD-L1 Inhibitor Versus Traditional Chemotherapy for Retreatment Small Cell Lung Cancer Patients
2022
·
Fengchun Mu
, Bingjie Fan
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
21
Citation count:
153
H-index:
8
I10-index:
6
Year
Topic
Type